Most people have heard of CBD. After all, products with CBD are in most major retailers and even our favorite celebrities are boasting about the benefits. But what if there was a cannabinoid that was similar to CBD, but worked even better? That’s CBDA! It’s time for the spotlight to shift from CBD to CBDA. Let’s take a look at what makes CBDA superior to CBD.
What is CBDA?
First, what is CBDA? CBDA is the precursor to CBD. When CBDA is decarboxylated, a process where cannabinoids are exposed to heat, CBDA converts to CBD. This poses a problem when extracting CBDA, as traditional extraction methods utilize heat in their extraction process. This causes a conversion of CBDA prior to the final extract, leaving little to none of the acidic cannabinoid left for consumers to enjoy. Due to the many benefits and advantages of CBDA, global solution providers have found ways to extract cannabinoids without the use of heat, allowing for the extraction of acidic cannabinoids at a mass scale.
What makes CBDA better than CBD?
CBDA has many advantages when compared to CBD, one of the most prominent being its extraordinary bioavailability. Bioavailability is the percentage or fraction of a drug or supplement that reaches the systemic circulation and is able to have an effect. A study published in the 24th Annual Symposium of the International Cannabinoid Research Society found CBDA is 19x more bioavailable than CBD. This means when an equivalent amount of CBD and CBDA is ingested, we are able to absorb much more CBDA! Additionally, it allows for lower doses of CBDA for therapeutic benefit for a variety of instances, including reducing inflammation, combatting nausea, and helping patients with anxiety and depression.
Many have taken notice of CBDA’s astounding bioavailability, including pharmaceutical companies. GW Pharma is the maker of Epidiolex, the only FDA approved drug with cannabinoids, in this case a fixed ratio of plant-derived CBD. Epidiolex is a drug that helps patients 2 years and older with various seizure disorders, and they are hoping to make an even better version with CBDA. They filed a patent for the therapeutic use of CBDA for seizure disorders and within the patent it was noted patients would need much less CBDA, than their CBD formula, to reduce the rate and severity of seizures. Additionally, CBDA was more effective than CBD in clinical trials as an anti-seizure therapeutic. They accredited these findings to CBDA’s heightened bioavailability.
Both CBD and CBDA are powerful cannabinoids that can be a great addition to one’s health and wellness routine. If you currently use a CBD product, try a product formulated with CBDA, to feel the elevated benefits for yourself.